MedTrace Logo

PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE

NCT04411407 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-04-01

No results posted yet for this study

Summary

A randomised, within-participants cross-over design trial including 34 patients with systemic lupus erythematosus. The participants will be randomised to data registration of patient reported outcome measures (PROM) through the DANBIO webapp and thereafter via the outpatient touchscreen or vice versa.

Conditions

Interventions

DEVICE

PROM registration via the DANBIO WebApp and the outpatient touchscreen in a randomised order

PROM registration via the DANBIO WebApp and the outpatient touchscreen in a randomised order

Sponsors & Collaborators

  • Salome Kristensen

    lead OTHER

Principal Investigators

  • Salome Kristensen, MD, PhD · Department of Rheumatology, Aalborg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2020-11-25
Completion
2020-11-25

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04411407 on ClinicalTrials.gov